- Home
- ACAD vs FRO Comparison
ACAD vs FRO Comparison
Compare ACAD & FRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACAD
- FRO
- Stock Information
- Founded
- ACAD 1993
- FRO 1985
- Country
- ACAD United States
- FRO Cyprus
- Employees
- ACAD N/A
- FRO N/A
- Industry
- ACAD Biotechnology: Pharmaceutical Preparations
- FRO Marine Transportation
- Sector
- ACAD Health Care
- FRO Consumer Discretionary
- Exchange
- ACAD Nasdaq
- FRO Nasdaq
- Market Cap
- ACAD 4.0B
- FRO 4.2B
- IPO Year
- ACAD 2004
- FRO N/A
- Fundamental
- Price
- ACAD $25.74
- FRO $20.56
- Analyst Decision
- ACAD Buy
- FRO Strong Buy
- Analyst Count
- ACAD 20
- FRO 3
- Target Price
- ACAD $28.63
- FRO $23.33
- AVG Volume (30 Days)
- ACAD 2.0M
- FRO 2.1M
- Earning Date
- ACAD 08-06-2025
- FRO 09-02-2025
- Dividend Yield
- ACAD N/A
- FRO 8.65%
- EPS Growth
- ACAD 615.00
- FRO N/A
- EPS
- ACAD 1.33
- FRO 1.56
- Revenue
- ACAD $1,018,885,000.00
- FRO $1,899,854,000.00
- Revenue This Year
- ACAD $13.28
- FRO N/A
- Revenue Next Year
- ACAD $10.88
- FRO $14.48
- P/E Ratio
- ACAD $18.70
- FRO $12.98
- Revenue Growth
- ACAD 14.41
- FRO 0.88
- 52 Week Low
- ACAD $13.40
- FRO $12.40
- 52 Week High
- ACAD $25.88
- FRO $25.68
- Technical
- Relative Strength Index (RSI)
- ACAD 66.52
- FRO 63.32
- Support Level
- ACAD $24.47
- FRO $18.43
- Resistance Level
- ACAD $25.88
- FRO $18.95
- Average True Range (ATR)
- ACAD 0.71
- FRO 0.64
- MACD
- ACAD 0.00
- FRO 0.10
- Stochastic Oscillator
- ACAD 94.62
- FRO 87.79
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.
About FRO Frontline Plc
Frontline PLC is an international shipping company engaged in the seaborne transportation of crude oil and oil products. Group operates through the tankers segment. The tankers segment includes crude oil tankers and product tankers. Its geographical area of operation includes Arabian Gulf, West African, the North Sea, and the Caribbean. Frontline earns revenue through voyage charters, time charters, and a finance lease. It is also involved in the charter, purchase, and sale of vessels.